Aim-Prospective survey of the effects of cisapride on QTc interval in
neonates given cisapride. Methods-QTc interval was determined just bef
ore and 2.9 (0.9) days after outset of the treatment in 49 neonates tr
eated with cisapride between 1 August 1995 and 29 February 1996. Resul
ts-Cisapride significancy increased QTc interval (p = 0.0001), and thi
s was higher when birthweight or gestational age were lower. The prolo
ngation of QTc interval above the arbitrary value of 0.450 (n = 7) was
clinically asymptomatic and was significantly more common in the infa
nts born with a gestational age less than or equal to 33 weeks (n = 6)
. Conclusion-The findings indicate that cisapride accumulates in less
mature neonates. Further pharmacokinetic studies are needed.